Guillaume Tauvel

Title: Innovations of Guillaume Tauvel

Introduction

Guillaume Tauvel is a notable inventor based in Rouen, France. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 3 patents, his work has implications for both medicinal chemistry and drug formulation.

Latest Patents

One of his latest patents is titled "Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer." This invention describes a precursor phase of the magnesium tetrahydrate salt of an omeprazole enantiomer, along with processes for preparing it and its applications in synthesizing the dihydrate form A of the magnesium salt of the enantiomer or as a medicament. Another significant patent is related to "Conglomerates of tenatoprazole potassium salts." This invention involves conglomerates of tenatoprazole potassium salts that consist of an equimolar mixture of enantiomers capable of crystallization in the form of a conglomerate. It also discusses a pharmaceutical composition containing such salts and their uses.

Career Highlights

Throughout his career, Guillaume Tauvel has worked with esteemed institutions such as Université de Rouen and Produits Chimiques Auxiliaires et de Synthèse. His work in these organizations has allowed him to advance his research and contribute to the field of chemistry.

Collaborations

He has collaborated with notable colleagues, including Gérard Coquerel and Marie-Noelle Petit. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Guillaume Tauvel's innovative work in the field of chemistry, particularly in pharmaceutical applications, showcases his expertise and dedication to advancing medicinal science. His patents reflect a commitment to improving drug formulations and therapeutic options.